Publicly Listing a Life Sciences Company in Copenhagen, New York and Stockholm

…and how best to partner and collaborate with Big Pharma to get there

How to navigate the listing process

The past few years have witnessed a growing number of Nordic life sciences companies tap the capital markets of Copenhagen, New York and Stockholm.

The paradigm for how Nordic life sciences companies have traditionally achieved financial exits for their investors in this region is changing, with more companies today seeking to publicly list their shares, sometimes even on more than one stock exchange. How are the life sciences capital markets working today, and what can be done to best prepare a Nordic life sciences company for a public listing?

This seminar, with contributions from leading industry experts, will examine the critical issues that executive management teams at life sciences companies must contemplate in advance of a public listing. It will also examine key licensing and collaboration structures and transactions that are often put in place in advance of and in support of successful public offerings.

Seminar topics:

• Why is the Nordic region a center for global life sciences activity?
• How is the Nordic investment community evolving to guide life sciences companies to publicly list?
• Will the growing number of public listings of life sciences companies attract more global venture capital investment to the region?
• What do the licensing and collaboration transactions look like that often underpin companies contemplating a listing?
• How are the public listings that are getting done being planned and structured?

There is no fee to attend, but space is limited.